Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicine

Acenocoumarol is the global standard of anticoagulant therapy, but often treatment with acenocoumarol accompanied by adverse drug reactions. Model of personalized medicine, actively developing now, can reduce the number of side effects during therapy of Acenocoumarol, mainly due to individual geneti...

Full description

Bibliographic Details
Main Authors: I V Kukes, V N Shan
Format: Article
Language:English
Published: Peoples’ Friendship University of Russia (RUDN University) 2009-12-01
Series:RUDN Journal of Medicine
Subjects:
Online Access:http://journals.rudn.ru/medicine/article/view/2526
_version_ 1819123403883282432
author I V Kukes
V N Shan
author_facet I V Kukes
V N Shan
author_sort I V Kukes
collection DOAJ
description Acenocoumarol is the global standard of anticoagulant therapy, but often treatment with acenocoumarol accompanied by adverse drug reactions. Model of personalized medicine, actively developing now, can reduce the number of side effects during therapy of Acenocoumarol, mainly due to individual genetic characteristics (polymorphisms of genes CYP2C9 and VKORC1). This will help to reduce side effects of therapy and reduce treatment costs.
first_indexed 2024-12-22T07:07:48Z
format Article
id doaj.art-7e3a81a35b92450da9d03f00ac878803
institution Directory Open Access Journal
issn 2313-0245
2313-0261
language English
last_indexed 2024-12-22T07:07:48Z
publishDate 2009-12-01
publisher Peoples’ Friendship University of Russia (RUDN University)
record_format Article
series RUDN Journal of Medicine
spelling doaj.art-7e3a81a35b92450da9d03f00ac8788032022-12-21T18:34:37ZengPeoples’ Friendship University of Russia (RUDN University)RUDN Journal of Medicine2313-02452313-02612009-12-01044214232526Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicineI V Kukes0V N Shan1Московская медицинская академия имени И.М. СеченоваМосковский государственный университет имени М.В. ЛомоносоваAcenocoumarol is the global standard of anticoagulant therapy, but often treatment with acenocoumarol accompanied by adverse drug reactions. Model of personalized medicine, actively developing now, can reduce the number of side effects during therapy of Acenocoumarol, mainly due to individual genetic characteristics (polymorphisms of genes CYP2C9 and VKORC1). This will help to reduce side effects of therapy and reduce treatment costs.http://journals.rudn.ru/medicine/article/view/2526здравоохранениесмертностькровотечения
spellingShingle I V Kukes
V N Shan
Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicine
RUDN Journal of Medicine
здравоохранение
смертность
кровотечения
title Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicine
title_full Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicine
title_fullStr Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicine
title_full_unstemmed Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicine
title_short Efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation, with using models of personalized medicine
title_sort efficiency of treatment by acenocoumarol in patients with permanent form of atrial fibrillation with using models of personalized medicine
topic здравоохранение
смертность
кровотечения
url http://journals.rudn.ru/medicine/article/view/2526
work_keys_str_mv AT ivkukes efficiencyoftreatmentbyacenocoumarolinpatientswithpermanentformofatrialfibrillationwithusingmodelsofpersonalizedmedicine
AT vnshan efficiencyoftreatmentbyacenocoumarolinpatientswithpermanentformofatrialfibrillationwithusingmodelsofpersonalizedmedicine